Basic Information
TELCORD 40 TABLET 40 MG
TABLET
Regulatory Information
SIN16640P
November 11, 2022
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
XC09CA07
Company Information
Active Ingredients
Strength: 40 MG
Detailed Information
Contraindications
**vii. Contraindication:** - Hypersensitivity to the active ingredient or any of the excipients - Second and third trimesters of pregnancy - Lactation - Biliary obstructive disorders - Severe hepatic impairment - The concomitant use of Telmisartan with aliskiren is contraindicated in patients with diabetes mellitus or renal impairment (GFR < 60 ml/min/1.73 m2) In case of rare hereditary conditions that may be incompatible with an excipient of the product (please refer to "special warnings and precautions" – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_) the use of the product is contraindicated.
Indication Information
**iv. Therapeutic Indication:** Treatment of essential hypertension. Reduction of the risk of non-fatal stroke or non-fatal myocardial infarction in patients 55 years or older at high risk of developing major cardiovascular events who cannot tolerate an angiotensin converting enzyme inhibitor (ACEI). High risk of cardiovascular events includes evidence of coronary artery disease, peripheral arterial disease, stroke, transient ischemic attack, or diabetes mellitus with evidence of end-organ damage.